Answer:
Explanation:
The more similar the two species are, the more their niche overlaps and the more competition there is.
<em>The most interesting results obtained in animal models of passive immunotherapies developed according to the “amyloid-beta cascade hypothesis” and the “Tau hypothesis” are monoclonal antibodies that directly or indirectly target Aβ plaques or neurofibrillary tangles. Unfortunately, these therapeutic antibodies cannot replicate their promising effects on humans at the clinical phase. Despite this, we still hope to learn from these failures and to explore new pathways. The great effects obtained in animals with passive immunotherapy suggest that this technology may be an important key to curative treatment. The remaining challenge is to find a way to achieve the same encouraging results for humans. Alzheimacy expects to join hands with global partners to focus on the development of therapeutic antibodies for Alzheimer’s disease (AD) and continue to fight against this disease.</em>
<em>https://www.creativebiomart.net/alzheimacy/therapeutics/therapeutic-antibody/</em>
Answer:
C) The allele R' is becoming more common in the population.
Answer:
All of the above is the answer.
An amino acid is a protein, there is 4 groups Carbohydrates, lipids, Proteins, sugars
<span>Examples of Evolution: Evolution
is the change over time. These changes may involve all aspects of life
including mutation, natural selection, genetic drift, thought and
technology.
Examples of animals evolving: </span>
<span>The lizard with extra sticky feet. ... The shrimp that lost its eyes. ... The owls that are changing color. ... The fish that's migrating earlier. ... The bedbugs with super-strength. ... <span>The mouse that's immune to poison. ...
</span></span><span><span>
</span></span><span><span>People do not evolve.
</span></span>